These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18068131)

  • 1. Taxanes, microtubules and chemoresistant breast cancer.
    McGrogan BT; Gilmartin B; Carney DN; McCann A
    Biochim Biophys Acta; 2008 Apr; 1785(2):96-132. PubMed ID: 18068131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.
    Murray S; Briasoulis E; Linardou H; Bafaloukos D; Papadimitriou C
    Cancer Treat Rev; 2012 Nov; 38(7):890-903. PubMed ID: 22465195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers predicting clinical benefit in breast cancer from microtubule-targeting agents.
    Pusztai L
    Ann Oncol; 2007 Dec; 18 Suppl 12():xii15-20. PubMed ID: 18083698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
    PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
    Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
    Yardley DA
    Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR).
    Fojo AT; Menefee M
    Semin Oncol; 2005 Dec; 32(6 Suppl 7):S3-8. PubMed ID: 16360716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.
    Wang R; Wang H; Wang Z
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive and Prognostic Value of the TauProtein in Breast Cancer.
    Bonneau C; Gurard-Levin ZA; Andre F; Pusztai L; Rouzier R
    Anticancer Res; 2015 Oct; 35(10):5179-84. PubMed ID: 26408675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.
    Cirak Y; Furuncuoglu Y; Yapicier O; Alici S; Argon A
    Int J Clin Exp Pathol; 2015; 8(5):5345-53. PubMed ID: 26191236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting microtubules for cancer chemotherapy.
    Zhou J; Giannakakou P
    Curr Med Chem Anticancer Agents; 2005 Jan; 5(1):65-71. PubMed ID: 15720262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
    BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.
    Mosca L; Ilari A; Fazi F; Assaraf YG; Colotti G
    Drug Resist Updat; 2021 Jan; 54():100742. PubMed ID: 33429249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.
    Wosnitzer MS; Domingo-Domenech J; Castillo-Martin M; Ritch C; Mansukhani M; Petrylack DP; Benson MC; McKiernan JM; Cordon-Cardo C
    J Urol; 2011 Nov; 186(5):2094-100. PubMed ID: 21944130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal instability, colorectal cancer and taxane resistance.
    Swanton C; Tomlinson I; Downward J
    Cell Cycle; 2006 Apr; 5(8):818-23. PubMed ID: 16628000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulin Proteins in Cancer Resistance: A Review.
    Kamal MA; Al-Zahrani MH; Khan SH; Khan MH; Al-Subhi HA; Kuerban A; Aslam M; Al-Abbasi FA; Anwar F
    Curr Drug Metab; 2020; 21(3):178-185. PubMed ID: 32101117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
    McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
    Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microtubule as a breast cancer target.
    Higa GM
    Breast Cancer; 2011 Apr; 18(2):103-19. PubMed ID: 20862571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.